Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples